The present status of cell tracking methods in animal models using magnetic resonance imaging technology

Molecules and Cells

Volumn 23, Issue 2, 2007, Pages 132-137

  Kim, Daehong ^a   Hong, Kwan Soo ^b   Song, Jihwan ^c  

^a National Cancer Center   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c CHA University   (South Korea)

Author keywords

Cell tracking; Magnetic resonance imaging; Stem cell therapy

Indexed keywords

CONTRAST MEDIUM; FERRITIN; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIC ACID; IRON; LANTHANIDE; LIPOFECTAMINE; MANGANESE; POLYLYSINE; PROTAMINE SULFATE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VSOP C184;

CANCER IMMUNOTHERAPY; CELL LABELING; CELL MIGRATION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; IN VIVO STUDY; KUPFFER CELL; LIVER TUMOR; LYMPH NODE METASTASIS; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; RELAXATION TIME; SENSITIVITY ANALYSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

ANIMALS; BRAIN DISEASES; CELL MOVEMENT; CELL TRANSPLANTATION; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; HEART DISEASES; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; STEM CELLS;

ANIMALIA;

EID: 34248177334     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (54)

1. Aime, S., Dastru, W., Crich, S. G., Gianolio, E., and Mainero, V. (2002) Innovative magnetic resonance imaging diagnostic agents based on paramagnetic Gd (III) complexes. Biopolymers 66, 419-428.
2. Anderson, S. A., Shukaliak-Quandt, J., Jordan, E. K., Arbab, A. S., Martin, R., et al. (2004) Magnetic resonance imaging of labeled T cells in a mouse model of multiple sclerosis. Ann. Neural. 55, 654-659.
3. Arbab, A. S., Yocum, G. T., Rad, A. M., Khakoo, A. Y., Fellowes, V., et al. (2005) Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 18, 553-559.
4. Baik, M., Henninghausen, L., and Choi, Y. (1997) In situ localization of WDNM1 and ferritin heavy chain gene expression in mammary gland. Mol. Cells 7, 448-450.
5. Bandettini, P. A., Jesmanowicz, A., Wong, E. C., and Hyde, J. S. (1993) Processing strategies for time-course data sets in functional MRI of the human brain. Magn. Reson. Med. 30, 161-173.
6. Blaimer, M., Breuer, F., Mueller, M., Heidemann, R. M., Griswold, M. A., et al. (2004) SMASH, SENSE, PILS, GRAPPA: how to choose the optimal method. Top. Magn. Reson. Imaging 5, 223-236.
7. Bruder, H., Fischer, H., Reinfelder, H. E., and Schmitt, F. (1992) Image reconstruction for echo planar imaging with nonequidistant k-space sampling. Magn. Reson. Med. 23, 311-323.
8. Bulte, J. W. and Kraitchman, D. L. (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484-499.
9. Bulte, J. W., Douglas, T., Witwer, B., Zhang, S. C., Strable, E., et al. (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141-1147.
10. Bulte, J. W., Zhang, S., van. Gelderen, P., Herynek, V., Jordan, E. K., et al. (1999) Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA 96, 15256-15261.
11. Clement, O., Siauve, N., Cuenod, C. A., and Frija, G. (1998) Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects. Top. Magn. Reson. Imaging 9, 167-182.
12. Cohen, B., Ziv, K., Plaks, V., Israely, T., Kalchenko, V., et al. (2007) MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat. Med. 13, 498-503.
13. Cunningham, C. H., Arai, T., Yang, P. C., McConnell, M. V., Pauly, J. M., et al. (2005) Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn. Reson. Med. 53, 999-1005.
14. Daldrup-Link, H. E., Rudelius, M., Oostendorp, R. A., Jacobs, V. R., Simon, G. H., et al. (2005a) Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX Acad. Radiol. 12, 502-510.
15. Daldrup-Link, H. E., Rudelius, M., Piontek, G., Metz, S., Brauer, R., et al. (2005b) Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 234, 197-205.
16. de Vries, I. J., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., et al. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23, 1407-1413.
17. Farzaneh, F., Riederer, S. J., and Pelc, N. J. (1990) Analysis of T2 limitations and off-resonance effects on spatial resolution and artifacts in echo-planar imaging. Magn. Reson. Med. 14, 123-139.
18. Foster-Gareau, P., Heyn, C., Alejski, A., and Rutt, B. K. (2003) Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn. Reson. Med. 49, 968-971.
19. Frank, J. A., Anderson, S. A., Kalsih, H., Jordan, E. K., Lewis, B. K., et al. (2004) Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 6, 621-625.
20. Frank, J. A., Miller, B. R., Arbab, A. S., Zywicke, H. A., Jordan, E. K., et al. (2003) Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228, 480-487.
21. Gillies, R. J. (2002) In vivo molecular imaging. J. Cell. Biochem. Suppl. 39, 231-238.
22. Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348, 2491-2499.
23. Hauger, O., Delalande, C., Trillaud, H., Deminiere, C., Quesson, B., et al. (1999) MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magn. Reson. Med. 41, 156-162.
24. Helm, L., Toth, E., and Merbach, A. E. (2003) Lanthanide ions as magnetic resonance imaging agents. Nuclear and electronic relaxation properties. Applications. Met. Ions. Biol. Syst. 40, 589-641.
25. Heyn, C., Bowen, C. V., Rutt, B. K., and Foster, P. J. (2005) Detection threshold of single SPIO-labeled cells with FIESTA. Magn. Reson. Med. 53, 312-320.
26. Hoehn, M., Kustermann, E., Blunk, J., Wiedermann, D., Trapp, T., et al. (2002) Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA 99, 16267-16272.
27. Josephson, L., Tung, C. H., Moore, A., and Weissleder, R. (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10, 186-191.
28. Kraitchman, D. L., Heldman, A. W., Atalar, E., Amado, L. C., Martin, B. J., et al. (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290-2293.
29. Lauffer, R. B. (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 87, 901-907.
30. Lauterbur, P. C. (1973) Image formation by induced local interactions. Examples employing nuclear magnetic resonance. Nature 242, 190-191.
31. Lauterbur, P. C., Mendonca, Dias. M. H., and Rudin, A. M. (1978) Augmentation of tissue water proton spin-lattice relaxation rates by in vivo addition of paramagnetic ions; in Frontiers of Biological Energetics, Dutton, P., Leigh, J. S., and Scarpa, A. (eds.), pp. 752-759, Academic Press, New York.
32. Mani, V., Briley-Saebo, K. C., Itskovick V. V., Samber, D. D., and Fayad, Z. A. (2006) Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn. Reson. Med. 55, 126-135.
33. Mansfield, P. (1977) Multi-planar image formation using NMR spin echos. J. Physics C10, L55-L58.
34. Matuszewski, L., Persigehl, T., Wall, A., Schwindt, W., Tombach, B., et al. (2005) Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 235, 155-161.
35. McLachlan, S. J., Morris, M. R., Lucas, M. A., Fisco, R. A., Eakins, M. N., et al. (1994) Phase I clinical evaluation of a new iron oxide MR contrast agent. J. Magn. Reson. Imaging 4, 301-307.
36. Meldrum, F. C., Heywood, B. R., and Mann, S. (1992) Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science 257, 522-523.
37. Metz, S., Bonaterra, G., Rudelius, M., Settles, M., Rummeny, E. J., et al. (2004) Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 14, 1851-1858
38. Modo, M., Hoehn, M., and Bulte, J. W. (2005) Cellular MR imaging. Mol. Imaging 4, 143-164.
39. Mori, S. and Zhang, J. (2006) Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51, 527-539.
40. Mukherjee, P. and McKinstry, R. C. (2006) Diffusion tensor imaging and tractography of human brain development. Neuroimaging. Clin. N. Am. 16, 19-43.
41. Muller, F. J., Snyder, E. Y., and Loring, J. F. (2006) Gene therapy: can neural stem cell deliver? Nat. Rev. Neurosci. 7, 75-84.
42. Na, H. B., Lee, J. H., An, K., Park, Y. I., Park, M., et al. (2007) Development of a T(1) contrast agent for magnetic resonance iImaging using MnO nanoparticles. Angew. Chem. Int. Ed. Engl. Mar 13; Epub ahead of print.
43. Rausch, M., Baumann, D., Neubacher, U., and Rudin, M. (2002) In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed. 15, 278-283.
44. Reimer, P., Marx, C., Rummeny, E. J., Muller, M., Lentschig, M., et al. (1997) SPIO-enhanced 2D-TOF MR angiography of the portal venous system: results of an intraindividual. comparison. J. Magn. Reson. Imaging 7, 945-949.
45. Rogers, W. J., Meyer, H., and Kramer, C. M. (2006) Technology insight: in vivo cell tracking by use of MRI. Nat. Clin. Prac. 3, 554-562.
46. Ruehm, S. G., Corot, C., Vogt, P., Kolb, S., and Debatin, J. F. (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415-422.
47. Shapiro, E. M., Skrtic, S., Sharer, K., Hill, J. M., Dunbar, C. E., et al. (2004) MRI detection of single particles for cellular imaging. Proc. Natl. Acad. Sci. USA 101, 10901-10906.
48. Shapiro, E. M., Sharer, K., Skrtic, S., and Koretsky, A. P. (2006) In vivo detection of single cells by MRI. Magn. Reson. Med. 55, 242-249.
49. Song, H., Kwon, K., Lim, S., Kang, S. M., Ko, Y. G., et al. (2005) Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol. Cells 19, 402-407.
50. Stark, D. D., Weissleder, R., Elizondo, G., Hahn, P. F., Saini, S., et al. (1988) Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168, 297-301.
51. Taupitz, M., Wagner, S., Schnorr, J., Kravec, I., Pilgrimm, H., et al. (2004) Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest. Radiol. 39, 394-405.
52. Turner, R., Howseman, A., Rees, G. E., Josephs, O., and Friston, K. (1998) Functional magnetic resonance imaging of the human brain: data acquisition and analysis. Exp. Brain. Res. 123, 5-12.
53. Weissleder, R. (1994) Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 193, 593-595.
54. Zitvogel, L. and Tursz, T. (2005) In vivo veritas. Nat. Biotechnol. 23, 1372-1374.